Study guide
2.3 Procedural Sedation & GI Pharmacology
Certified Gastroenterology Registered Nurse CGRN
Track your progress as you read
Finished sections get a check mark.
1 Introduction & CGRN Exam Overview
1.1 CGRN Exam Facts & Logistics 1.2 Eligibility & Application 1.3 Exam Blueprint & Study Strategy
2 General Nursing Care in the GI Setting
2.1 GI Anatomy & Physiology Review 2.2 Patient Assessment & Pre-Procedure Preparation 2.3 Procedural Sedation & GI Pharmacology
3 Gastroenterological Procedures & Therapeutic Interventions
3.1 Diagnostic Endoscopy (EGD & Colonoscopy) 3.2 Advanced Procedures (ERCP, EUS, Enteroscopy, Capsule) 3.3 Therapeutic & Hemostatic Interventions 3.4 Motility Studies & Specialized Testing
4 Patient Care Interventions
4.1 Intra- & Post-Procedure Monitoring 4.2 Recognition & Management of Complications 4.3 Recovery, Discharge & Patient Education
5 Environmental Safety, Infection Prevention & Control
5.1 Endoscope Reprocessing 5.2 Infection Prevention & Standard Precautions 5.3 Environmental & Occupational Safety
6 Final Review & Test-Day Strategy
6.1 High-Yield Recap by Domain 6.2 Scaled Scoring & Exam Readiness 6.3 Test-Day Strategy & Common Pitfalls
2.3 Procedural Sedation & GI Pharmacology
Key Takeaways Explain This Topic AI
Moderate (conscious) sedation preserves purposeful response and protective airway reflexes; deep sedation may impair them and requires higher monitoring and rescue capability.
Midazolam (a benzodiazepine) and fentanyl (an opioid) are common moderate-sedation agents; their reversal agents are flumazenil and naloxone, respectively.
Propofol produces rapid deep sedation with no pharmacologic reversal agent and is administered under protocols requiring qualified, dedicated monitoring.
Continuous monitoring during sedation includes level of consciousness, oxygen saturation, capnography or ventilation assessment, heart rate, blood pressure, and ECG when indicated.
Common GI pharmacology includes proton pump inhibitors (PPIs), prokinetics, simethicone, and antispasmodics, each with a defined procedural role.
Last updated: June 2026
Why Sedation Is the Highest-Yield Topic
Sedation safety is one of the highest-yield areas of the General Nursing Care domain because sedation-related cardiopulmonary events — chiefly respiratory depression — are among the most common preventable endoscopy complications. The CGRN tests whether you can distinguish sedation depth, dose and monitor safely, recognize oversedation early, and rescue the patient. The single most-tested principle: any clinician administering sedation must be able to rescue a patient from one level deeper than the intended target.
Levels of Sedation
Sedation exists on a continuum, and a patient can drift into a deeper level than intended. Know the defining features of each level cold.
- Level Responsiveness Airway Spontaneous Ventilation Cardiovascular
- Minimal (anxiolysis) Normal response to voice Unaffected Unaffected Unaffected
Moderate (conscious) Purposeful response to voice or light touch No intervention required Adequate Usually maintained
Deep Purposeful response only after repeated or painful stimulation Intervention may be required May be inadequate Usually maintained
General anesthesia Not arousable, even to pain Intervention often required Frequently inadequate May be impaired
Note that withdrawal from a painful stimulus is a reflex and does NOT count as purposeful response — a common exam distractor. The critical distinction for nurse-administered sedation is that moderate sedation preserves a patent airway and adequate breathing, while deep sedation may not. Because patients can move from moderate to deep sedation unintentionally, rescue skills and equipment must be ready before the first dose.
- Sedation Agents and Reversal
- Midazolam (Benzodiazepine)
Midazolam provides sedation, anxiolysis, and anterograde amnesia , with onset in 1-2.5 minutes IV and peak effect by 3-5 minutes. It is titrated to effect in small increments. Its principal risk is respiratory depression, potentiated when combined with opioids. The reversal agent is flumazenil , a competitive benzodiazepine antagonist; watch for re-sedation because flumazenil's duration (about 30-60 minutes) is often shorter than midazolam's, and it can precipitate seizures in benzodiazepine-dependent patients.
Fentanyl (Opioid)
Fentanyl is a short-acting synthetic opioid providing analgesia and mild sedation, with rapid IV onset (1-2 minutes). Its main risk is dose-dependent respiratory depression, again amplified with a benzodiazepine. The reversal agent is naloxone , an opioid antagonist. As with flumazenil, naloxone may wear off before the opioid does, so monitor for recurrent respiratory depression and be prepared to redose.
Propofol
Propofol is a rapid-onset, short-duration sedative-hypnotic that can quickly produce deep sedation or general anesthesia. It has no reversal agent , a narrow margin between moderate and deep sedation, and causes dose-dependent hypotension and apnea. Because of these properties, propofol is administered under institution-specific protocols, frequently by an anesthesia provider or a qualified clinician whose sole responsibility is monitoring and managing the patient and airway.
- Agent Class Reversal Agent Key Caution
- Midazolam Benzodiazepine Flumazenil Respiratory depression; re-sedation after reversal
- Fentanyl Opioid Naloxone Respiratory depression; synergistic with benzodiazepines
- Propofol Sedative-hypnotic None Rapid deep sedation, apnea, hypotension
Monitoring Standards
During procedural sedation, monitoring is continuous and documented at defined intervals (typically every 5 minutes, more often during the periprocedure peak). Core parameters:
Level of consciousness — response to verbal and tactile stimulation; the earliest indicator of deepening sedation.
Oxygenation — continuous pulse oximetry (SpO2).
Ventilation — respiratory rate and depth plus capnography (end-tidal CO2) , which detects hypoventilation and apnea earlier than pulse oximetry alone, especially when supplemental oxygen masks a falling saturation.
Hemodynamics — heart rate and blood pressure at regular intervals; electrocardiogram (ECG) for patients with cardiac risk or deeper sedation.
A dedicated, qualified individual whose primary responsibility is monitoring should not also perform the procedure. Emergency airway equipment, suction, oxygen, a bag-valve mask, and reversal agents must be immediately available before sedation begins. Recovery monitoring continues until the patient meets validated discharge criteria (e.g., Aldrete score) — return to baseline mentation, stable vital signs, controlled pain and nausea, and a responsible escort.
GI Pharmacology Around Endoscopy
Drug Class Examples Procedural Role
Proton pump inhibitors (PPIs) Omeprazole, pantoprazole Reduce gastric acid; used pre/post for bleeding ulcers and esophagitis
Prokinetics Metoclopramide, erythromycin Promote gastric emptying; given before urgent EGD to clear the stomach
Simethicone Simethicone Antifoaming agent that reduces bubbles and improves mucosal visualization
Antispasmodics Glucagon, hyoscine/anticholinergics Reduce peristalsis to aid difficult cannulation, ERCP, or polypectomy
Documentation
Thorough documentation is a patient-safety and medico-legal requirement. The sedation record should capture the baseline assessment, ASA class, each drug with dose/route/time, titration, monitoring values at defined intervals, any reversal agents given, complications and interventions, the patient's response, and discharge readiness against objective criteria. A timed "time-out" verifying correct patient, procedure, and site precedes every case, and the procedure note should record scope insertion and withdrawal times where relevant.
"If it wasn't documented, it wasn't done" is the operative medico-legal standard, and complete records also support quality benchmarking and reimbursement.